<div id="main-content">
<h2 class="title"><span class="in"><span style="color: rgb(255, 255, 255);">Biopharming</span></span></h2>
<div class="collection-navigation photo-navigation">
<div class="previous-page" id="previous-photo"><a class="imageLink" href="tracking-experiments.html#previous-photo">Previous</a></div>
<div class="next-page" id="next-photo"><a class="imageLink" href="gene-therapy.html#previous-photo">Next</a></div>
<div class="collection-index" id="photo-list"><a class="imageLink" href="./">List</a></div>
</div>
<div class="article">
<div class="article-content">
<div class="RichTextElement">
<div>
<div class="first callout-container">
<div class="callout">
<div class="callout-content">
<div class="pagelet untitled i1 o last-item">
<div class="pagelet-body">
<div class="RichTextElement">
<div>
<p><img alt="ninja icon" class="first narrow left graphic-container" height="51" src="../../../_Media/ninja-icon_med.png" width="76"/></p><p><strong><span style="font-size: 16px; font-family: 'Arial Black';">Understanding:</span></strong></p><p><span style="font-size: 16px; font-family: Arial;">â¢ Â Biopharming uses genetically modified animals and plants to produce proteins for therapeutic use</span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<p><span style="font-size: 18px; font-family: Arial;">Â  Â  Â Â </span><span style="font-family: Arial;"><br/></span><span style="font-size: 16px; font-family: Arial;"><strong>Biopharming</strong> involves using transgenic plants or animals to produce (orÂ <em>âfarmâ</em>) pharmaceutical products for therapeutic use</span></p><ul><li><span style="font-size: 16px; font-family: Arial;">This involves the insertion of target genes into hosts (crops or animals) that would not normally express those genes</span></li><li><span style="font-size: 16px; font-family: Arial;">The desired compound can potentially be expressed in a form that is routinely harvested (e.g. milk, eggs, fruits, etc.)</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/>There are several established examples of biopharming, including:</span></p><ul><li><span style="font-size: 16px; font-family: Arial;">Transgenic sheep that produce humanÂ </span><span style="color: rgb(0, 0, 0); font-family: Arial; font-size: 16px;">Î±-1-antitrypsin in their milk (individuals deficient in this enzyme develop emphysema)</span></li><li><span style="color: rgb(0, 0, 0); font-family: Arial; font-size: 16px;">Crops that express attenuated antigenic fragments for specific pathogenic diseases (i.e. edible vaccines)Â </span></li></ul><p><span style="font-size: 16px; font-family: Arial; color: rgb(0, 0, 0);"><br/></span></p>
<div class="not-first-item callout-container">
<div class="callout">
<div class="callout-content">
<div class="pagelet untitled i1 o last-item">
<div class="pagelet-body">
<div class="RichTextElement">
<div>
<p><img alt="ninja icon" class="first narrow left graphic-container" height="51" src="../../../_Media/ninja-icon_med.png" width="76"/></p><p><strong><span style="font-size: 16px; font-family: 'Arial Black';">Application:</span></strong></p><p><span style="font-size: 16px; font-family: Arial;">â¢ Â Biopharming of antithrombin</span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<p><span style="font-size: 18px; font-family: Arial;">Â  Â  Â Â </span><span style="font-family: Arial;"><br/></span><span style="font-size: 16px; font-family: Arial;">Antithrombin is a blood protein which inactivates certain enzymes in the coagulation system to prevent excessive clotting</span><span style="font-size: 16px; font-family: Arial; color: rgb(0, 0, 0);"><br/></span></p><ul><li><span style="font-size: 16px; font-family: Arial;">Individuals with a genetic or acquired antithrombin deficiency are at an increased risk of developing damaging blood clots</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/>Genetically engineered antithrombin has been biopharmed from transgenic goats to produce stocks for commercial use</span></p><ul><li><span style="font-size: 16px; font-family: Arial;">A human gene encoding for antithrombin is introduced into the fertilised egg of a goat</span></li><li><span style="font-size: 16px; font-family: Arial;">The modified eggs are implanted into the uterus of surrogates, which give birth to transgenic offspring</span></li><li><span style="font-size: 16px; font-family: Arial;">The transgenic offspring will produce human antithrombin in its milk, which can then be extracted and purified</span></li><li><span style="font-size: 16px; font-family: Arial;">Each year, the transgenic goat can produce a quantity of antithrombin equivalent to 90,000 human blood donations</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p><p style="text-align: center;"><u><span style="font-size: 18px; font-family: Arial;"><strong>Biopharming of Antithrombin</strong></span></u></p>
<div class="not-first-item graphic-container wide center ImageElement">
<div class="graphic">
<div class="figure-content">
<!-- sandvox.ImageElement --><img alt="biopharming" height="385" src="../../../_Media/biopharming_med.jpeg" width="783"/>
<!-- /sandvox.ImageElement --></div>
</div>
</div><p><br/></p>
</div>
</div>
</div> <!-- /article-content -->
<div class="article-info">
</div> <!-- /article-info -->
</div> <!-- /article -->
</div>